Nonalcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Nonalcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic Steatohepatitis [Phase 2]
Phase 2 clinical trial evaluating fecal microbiota transfer for efficacy, safety, and tolerability in patients with nonalcoholic steatohepat…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis [Phase 3]
Phase 3 study evaluating obeticholic acid for compensated cirrhosis due to nonalcoholic steatohepatitis has completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patients [Phase 4]
Phase 4 trial comparing raltegravir-based antiretroviral therapy to maintaining any other ART in HIV mono-infected patients; completed study…
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 trial update for PXL065 in nonalcoholic steatohepatitis (NASH) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver Disease [NA]
A clinical trial investigating quantitative ultrasound with Liver InCytes for evaluating non-alcoholic fatty liver disease was terminated; r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Vitamin E for NASH Treatment in HIV Infected Individuals [Phase 2]
A Phase 2 trial studying vitamin E for treating nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in individuals with HIV wa…
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Noninvasive Biomarkers of Metabolic Liver Disease 1.1 [NA]
A completed clinical trial from Massachusetts General Hospital investigating noninvasive biomarkers for metabolic liver disease, including n…
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis [Phase 3]
Clinical trial comparing rosuvastatin to CoQ10 for nonalcoholic steatohepatitis in Phase 3; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: CM-101 in NASH Patients - The SPLASH Study [Phase 2]
Phase 2 trial update for CM-101 in nonalcoholic steatohepatitis (NASH) from the SPLASH study; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis [Phase 2]
Phase 2 clinical trial assessing pharmacodynamics and safety of coadministered DGAT2 inhibitor and ACC inhibitor in participants with presum…
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD [Phase 1, Phase 2]
Phase Ib/II trial evaluating GH509 versus placebo for NASH/NAFLD is ongoing; no results yet from the study.
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Leronlimab (PRO 140) in Patients With Nonalcoholic Steatohepatitis [Phase 2]
Phase 2 clinical trial of leronlimab (PRO 140) in nonalcoholic steatohepatitis (NASH) has completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 trial update for various treatments in NAFLD with aspects of NASH; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis [Phase 2]
Phase 2 trial of experimental medication BMS-986036 in adults with nonalcoholic steatohepatitis (NASH) and liver cirrhosis has completed wit…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis [Phase 1, Phase 2]
A terminated Phase 1/2 clinical trial evaluating probiotics for non-alcoholic fatty liver disease and steatohepatitis; results have been pos…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of Guanabenz for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis…
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Phase 2a Study of HPG1860 in Subjects With NASH [Phase 2]
Phase 2a study update for HPG1860 in NASH (nonalcoholic steatohepatitis) is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis [Phase 2]
Phase 2 trial update of experimental medication BMS-986036 in adults with nonalcoholic steatohepatitis and stage 3 liver fibrosis; study com…
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 clinical trial studying miricorilant for nonalcoholic steatohepatitis (NASH) has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH [Phase 2]
Phase 2 trial evaluating ALS-L1023 for nonalcoholic steatohepatitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials
Completed clinical trial related to 13C-Methacetin breath tests in NASH (nonalcoholic steatohepatitis) with posted results.
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) [Phase 2]
A Phase 2 trial evaluating Efruxifermin for nonalcoholic steatohepatitis (NASH) has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects [Phase 2]
Phase 2 trial update for CRV431 in NASH patients with F2-F3 fibrosis; study completed and results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-05Clinical Trial Update: A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 clinical trial of seladelpar for nonalcoholic steatohepatitis (NASH) was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis [Phase 2]
Phase 2 clinical trial update for FM101 in adults with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis.